ClinicalTrials.gov
ClinicalTrials.gov Menu

Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01604616
Recruitment Status : Unknown
Verified May 2012 by Ziv Hospital.
Recruitment status was:  Recruiting
First Posted : May 23, 2012
Last Update Posted : May 23, 2012
Sponsor:
Information provided by (Responsible Party):
Ziv Hospital

Brief Summary:
The purpose of the article is, to investigate the efficacy and safety of perfluorocarbon liquid (PFCL) ,as a short term postoperative tamponade for treating retinal detachment ,associated with giant retinal tears.

Condition or disease
Retinal Detachment

Detailed Description:
a retrospective study wich compared 2 groups that had giant tear repair in one group, PFCL was left for few days as an intermediate measure until silicone oil or SF6 gas was used to reattach the retina ,and in the control group SF6 or Silicone oil were used, with no PFCL.

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears
Study Start Date : January 1998
Estimated Study Completion Date : June 2012

Resource links provided by the National Library of Medicine


Group/Cohort
PCFL GROUP
patients in this group had the PFCL for a period of 7-10 days before it was replaced by SF6 gas or silicone oil
control group
in thos group no PFCL was left in the eye and either SF6 or silicone oil was the definitive treatment at the time of the retinal detachment surgery repair.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
man and women above the age of 18 years
Criteria

Inclusion Criteria:

  • above 18 years of age
  • retinal tear at least of 3 clock hours.

Exclusion Criteria:

  • less than 18 years of age
  • Retinal tear less than 3 hours

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01604616


Locations
Israel
Ziv Medical Center Recruiting
Safed, Israel
Contact: Joseph Pikkel, M.D       pikel.y@ziv.health.gov.il   
Contact: Otzem Chassid, M.D       otzem.c@ziv.health.gov.il   
Sponsors and Collaborators
Ziv Hospital
Investigators
Principal Investigator: Joseph pikkel, M.D Ziv Medical Center

Responsible Party: Ziv Hospital
ClinicalTrials.gov Identifier: NCT01604616     History of Changes
Other Study ID Numbers: 0032-12-ZIV
First Posted: May 23, 2012    Key Record Dates
Last Update Posted: May 23, 2012
Last Verified: May 2012

Additional relevant MeSH terms:
Retinal Detachment
Retinal Perforations
Retinal Diseases
Eye Diseases